|
Division of
Endocrinology and Metabolism
Adler RA., Curtis JR., Saag K.,
Weinstein RS. Glucocorticoid-Induced
Osteoporosis. In Marcus R, Feldman D, Nelsen DA, Rosen CJ (eds)
Osteoporosis 3rd Edition ed. Elsevier, Amsterdam: 2008.
Chapter 1135-1166.
Aguirre JI,
Plotkin LI, Gortazar AR, Millan
MM, O'Brien CA, Manolagas SC, Bellido T.
A novel ligand-independent function of the estrogen receptor is
essential for osteocyte and osteoblast mechanotransduction. J
Biol Chem 2007 Aug; 282(35):25501 - 25508.
Ahmed HN., Chhaya SK.,
Makdissi A., Zimmerman RS.
Diabetic muscle infarction: case report of a rare complication.
Am J Med 2007 Jul; 120(7):e3-5.
Ali AA,
Weinstein RS, Stewart SA,
Parfitt AM, Manolagas SC,
Jilka RL. Rosiglitazone causes bone loss in mice by
suppressing osteoblast differentiation and bone formation.
Endocrinology 2005;146(3):1226-35.
Almeida M,
Han L, Bellido T, Manolagas SC, Kousteni
S. Wnt proteins prevent apoptosis of both uncommitted
osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent
and -independent signaling cascades involving Src/ERK and
phosphatidylinositol 3-kinase/AKT. J Biol Chem 2005;
280(50):41342-51.
Almeida
M;Han L;O'Brien CA;Kousteni S;Manolagas SC; Classical
genotropic versus kinase-initiated regulation of gene
transcription by the estrogen receptor alpha. Endocrinology
2006 Apr 147 (4): 1986 - 1996.
Almeida
M;Han L;Martin-Millan M;Plotkin
LI;Stewart SA;Roberson PK;Kousteni
S;O'Brien CA;Bellido T;Parfitt AM;Weinstein RS;Jilka
RL;Manolagas SC; Skeletal involution by
age-associated oxidative stress and its acceleration by loss of
sex steroids. J Biol Chem 2007 Sep 14 282 (37): 27285 -
27297.
Almeida
M;Han L;Martin-Millan M;O'Brien
CA;Manolagas SC; Oxidative stress antagonizes Wnt
signaling in osteoblast precursors by diverting beta-catenin
from T cell factor- to forkhead box O-mediated transcription.
J Biol Chem 2007 Sep 14 282 (37): 27298 - 27305.
Banga A;Bodles AM;Rasouli
N;Ranganathan G;Kern PA;Owens RJ; Calcium is involved
in formation of high molecular weight adiponectin. Metab
Syndr Relat Disord 2008 6 (2): 103 - 111.
Bansal D, Nanda A, Gupta E, Croker
M, Williams M, Bacchus A, Simmons D, Erbland M. Myxedema Coma
in a Patient with Donn’s Syndrome. Ark Med J 2006; 103 (5):
112-3.
Bellido T,
Ali AA, Gubrij I, Plotkin LI, Fu
Q, O'Brien CA, Manolagas SC, Jilka RL.
Chronic elevation of parathyroid hormone in mice reduces
expression of sclerostin by osteocytes: a novel mechanism for
hormonal control of osteoblastogenesis. Endocrinology
2005; 146(11):4577-83.
Bellido T. Downregulation of Sost/Sclerostin
by PTH: A novel mechanism of hormonal control of bone formation
mediated by osteocytes. J Musculoskelet. Neuronal Interact
2006; 6:358-9.
Bellido T. Summary – Osteocyte
control of bone formation via Sost/sclerostin.
J Musculoskelet
Neuronal Interact 2006; 6:360-3.
Bellido T. The osteocyte: The
“third” cell of bone gets to center stage (Report from the 28th
annual meeting of the American Society for Bone and Mineral
Research). BoneKEy-Osteovision 2006; (11) 14-50.
Bi Y, Stuelten
CH, Kilts T, Wadhwa S, Iozzo RV, Robey PG,
Chen XD, Young MF. Extracellular matrix
proteoglycans control the fate of bone marrow stromal cells.
J Biol Chem 2005; 280(34):30481-9.
Billow A. Ahmed ., Brandon C.
Jeffus., Syed I. A. Bukhari., Justin T. Harney.,
Resat Unal., Vladimir V.
Lupashin., Peter van der Sluijs. Serotonin transamidates Rab4
and facilitates its binding to the C terminus of serotonin
transporter. J Biol Chem. 2008 April; 283(14):9388-9398.
Bodles AM,
Banga A, Rasouli N, Ono F,
Kern PA, Owens RJ. Pioglitazone increases secretion
of high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab 2006; 291(5):E1100-E1105.
Bodles AM,
Varma V, Yao-Borengasser A,
Phanavanh B, Peterson CA, McGehee RE, Jr.,
Rasouli N, Wabitsch M,
Kern PA. Pioglitazone induces
apoptosis of macrophages in human adipose tissue. J Lipid Res
2006;47(9):2080-8.
B. Brenner., J. T. Harney., B. A.
Ahmed., B. C. Jeffus., R. Unal.,
J. L. Mehta., F. Kilic. Plasma serotonin levels and the platelet
serotonin transporter. J Neurochem. 2007 July;
102(1):206-15.
Chen JR,
Plotkin LI, Aguirre JI,
Han L, Jilka RL, Kousteni
S, Bellido T, Manolagas SC. Transient
versus sustained phosphorylation and nuclear accumulation of
ERKs underlie anti-versus pro-apoptotic effects of estrogens.
J Biol Chem 2005; 280(6):4632-8.
Chen XD;Dusevich V;Feng JQ;Manolagas
SC;Jilka RL; Extracellular matrix made by bone marrow
cells facilitates expansion of marrow-derived mesenchymal
progenitor cells and prevents their differentiation into
osteoblasts. J Bone Miner Res 2007 Dec 22 (12): 1943 -
1956.
Choksi P, Thomas R,
Simmons DL. Charcot arthropathy.
An often overlooked complication of diabetes mellitus. J Ark Med
Soc 2007; 103(9):229-31.
Chu WS, Das
SK, Wang H, Chan JC, Deloukas P, Froguel P, Baier LJ,
Jia W, McCarthy MI, Ng MC, Damcott C, Shuldiner AR, Zeggini E,
Elbein SC. Activating
transcription factor 6 (ATF6) sequence polymorphisms in type 2
diabetes and pre-diabetic traits. Diabetes 2007; 56(3):856-62.
Craig RL, Chu WS,
Elbein SC. Retinol binding
protein 4 as a candidate gene for type 2 diabetes and
prediabetic intermediate traits. Mol Genet Metab 2007;
90(3):338-44.
Das SK.
Assessing the function of genetic variants involved in Type 2
Diabetes mellitus: In Silico. Molecular and Cellular
Proteomics 2005; June 29;[electronic letter to the Editor].
Das SK. The Indian Genome
Variation database (IGVdb): a project overview. Hum Genet
2005; 118(1):1-11.
Das SK,
Chu WS, Hale TC, Wang X, Craig RL, Wang
H, Shuldiner AR, Froguel P, Deloukas P, McCarthy MI,
Zeggini E, Hasstedt SJ, Elbein SC.
Polymorphisms in the glucokinase-associated, dual-specificity
phosphatase 12 (DUSP12) gene under chromosome 1q21 linkage peak
are associated with type 2 diabetes. Diabetes 2006;
55(9):2631-9.
Das SK, Elbein SC. The Genetic Basis
of Type 2 Diabetes. Cellscience Reviews. 2006; 2:100-131.
Das SK.
Genetic Epidemiology of adult onset Type 2 Diabetes in Asian
Indian Population: Past, Present and Future. Int J Hum Genet
[Special Issue on: Epidemiology of Genetic Diseases in India].
2006; 6(1):1.
Das SK.
Thr394Thr polymorphism (rs2970847) of PPARGC1A gene and obesity
in Asian Indians. Int J Obes (Lond). 2007; 31(3):562-3.
Das SK, Elbein SC. The search for
type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diab Rep 2007; 7(2):154-64.
DAS SK.,
Chu WS., Mondal AK., Sharma NK., Kern
PA., Rasouli N., Elbein SC. Effect of Pioglitazone
Treatment on Endoplasmic Reticulum Stress Response in Human
Adipose and in Palmitate Induced Stress in Human Liver and
Adipose Cell Lines. Am J Physiol Endocrinol Metab 2008
Jun; 295(2):393-400.
DAS SK;Sharma
NK;Chu WS;Wang H;Elbein SC;
Aryl hydrocarbon receptor nuclear translocator (ARNT) gene as a
positional and functional candidate for type 2 diabetes and
prediabetic intermediate traits: Mutation detection,
case-control studies, and gene expression analysis. BMC Med
Genet 2008; 9, 16.
DAS SK;Chu
WS;Mondal AK;Sharma NK;Kern PA;Rasouli
N;Elbein SC; Effect of Pioglitazone Treatment on
Endoplasmic Reticulum Stress Response in Human Adipose and in
Palmitate Induced Stress in Human Liver and Adipose Cell Lines.
Am J Physiol Endocrinol Metab 2008 Jun 10.
Di Gregorio GB,
Yao-Borengasser A, Rasouli N,
Varma V, Lu T, Miles LM,
Ranganathan G, Peterson CA, McGehee RE,
Kern PA. Expression of CD68
and macrophage chemoattractant protein-1 genes in human adipose
and muscle tissues: association with cytokine expression,
insulin resistance, and reduction by pioglitazone. Diabetes
2005; 54(8):2305-13.
Elbein SC,
Wang X, Karim MA, Freedman BI, Bowden DW, Shuldiner AR, Brancati
FL, Kao WH. Role of a proline insertion in the insulin promoter
factor 1 (IPF1) gene in African Americans with type 2 diabetes.
Diabetes 2006; 55(10):2909-14.
Elbein SC,
Wang X, Karim MA, Chu WS, Silver KD. Analysis of coding variants
in the betacellulin gene in type 2 diabetes and insulin
secretion in African American subjects. BMC Med Genet 2006;
7:62.
Elbein SC;Chu
WS; DAS SK;Yao-Borengasser A;Hasstedt
SJ;Wang H;Rasouli N;Kern PA;
Transcription factor 7-like 2 polymorphisms and type 2 diabetes,
glucose homeostasis traits and gene expression in US
participants of European and African descent. Diabetologia
2007 Aug 50 (8): 1621 - 1630.
Elbein SC; Evaluation of
polymorphisms known to contribute to risk for diabetes in
African and African-American populations. Curr Opin Clin Nutr
Metab Care 2007 Jul 10 (4): 415 - 419.
Elbein SC;Rasouli N;
Intermuscular lipid: a marker of disordered fat partitioning or
the consequence of obesity?. Am J Clin Nutr 2008 Jun 87
(6): 1585 - 1586.
Faas F.
Clinical Obstetrics: The Fetus and Mother. Third edition ed.
Malden, MA: Blackwell Publishing; 2007. Chapter 42. Endocrine
Disorders in Pregnancy.
Fu Q,
Manolagas SC, O'Brien CA. Parathyroid hormone
controls receptor activator of NF-kappaB ligand gene expression
via a distant transcriptional enhancer. Mol Cell Biol 2006;
26(17):6453-68.
Galli C., Zella LA., Fretz JA., Fu
Q., Pike JW., Weinstein RS., Manolagas
SC., O'Brien CA. Targeted deletion of a distant
transcriptional enhancer of the RANKL gene reduces bone
remodeling and increases bone mass. Endocrinology
149:146-153 2007 .
Galli C, Zella LA, Fretz JA, Fu Q,
Pike JW, Weinstein RS, Manolagas SC,
O'Brien CA. Targeted deletion of a distant
transcriptional enhancer of the receptor activator of nuclear
factor-kappaB ligand gene reduces bone remodeling and increases
bone mass. Endocrinology 2008 Jan; 149(1):146 - 153.
Gupta B,
Agrawal C, Raghav SK, Das SK,
Das RH, Chaturvedi VP, Das HR. Association of mannose-binding
lectin gene (MBL2) polymorphisms with rheumatoid arthritis in an
Indian cohort of case-control samples. J Hum Genet 2005;
50(11):583-91.
Govindarajan R, Ratnasinghe LD,
Simmons DL, Siegel ER,
Midathada MS, Kim L, Kim P, Owens RJ,
Lang NP. Thiazolidinediones (TZD) and the risk of lung,
prostate and colon cancer in diabetic subjects. J Clin
Oncol 2007; 25(12):1476-81.
Hamid Z, Simmons D.
Letter to the
Editor: Triple Therapy in Type 2 Diabetes: Insulin glargine or
rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients. Diabetes Care 2006; 29:
2331.
Z Hamid.,
Faas F. Cyclical Cushing's syndrome due to bronchial
carcinoid: early diagnosis and prompt treatment. Cyclical
Cushing's syndrome 2008 April; 18(2):95-100.
Hasstedt SJ;Chu WS;DAS
SK;Wang H;Elbein SC; Type 2 diabetes susceptibility
genes on chromosome 1q21-24. Ann Hum Genet 2008 Mar 72
(Pt 2): 163 - 169.
Ioachimescu AG.,
Makdissi A., Lichtin A.,
Zimmerman RS. Thyroid Disease in Patients with Immunologic
Thrombocytopenia: a Cohort Study. Thyroid 2007 Nov;
17(11):1173-42.
Jia D,
O'Brien CA, Stewart SA,
Manolagas SC, Weinstein RS. Glucocorticoids act
directly on osteoclasts to increase their life span and reduce
bone density. Endocrinology 2006; 147(12):5592-9.
Jilka
RL;Weinstein RS;Parfitt AM;Manolagas SC; Quantifying
osteoblast and osteocyte apoptosis: challenges and rewards. J
Bone Miner Res 2007 Oct 22 (10): 1492 - 1501.
Jilka RL;
Molecular and cellular mechanisms of the anabolic effect of
intermittent PTH. Bone 2007 Jun 40 (6): 1434 - 1446.
Jilka RL.,
Bellido T., Almeida M., Plotkin LI., O'Brien CA., Weinstein RS.,
Manolagas SC. (In Press). Principles of Bone
Biology. 3rd ed. New York: Academic Press, Inc.; 2008.
Chapter 13. Apoptosis of Bone Cells.
1.
Jilka RL, O’Brien CA, Ali AA, Roberson PK,
Weinstein RS, Manolagas SC.
Intermittent PTH Stimulates Periosteal Bone Formation by Actions
on Post-mitotic Preosteoblasts.
Bone, [Epub ahead
of print] 2008.
Karim MA, Wang
X, Hale TC, Elbein SC.
Insulin Promoter Factor 1 variation is associated with type 2
diabetes in African Americans. BMC Med Genet; 6:37, 2005.
Karim MA, Craig RL, Wang X, Hale TC,
Elbein SC. Analysis of
FOXO1A as a candidate gene for type 2 diabetes. Mol Genet Metab
2006; 88(2):171-7.
Kern PA, Rasouli N. The pathogenesis
and treatment of high-risk obesity. In: Fonseca V, editor.
Clinical Diabetes. Philadelphia, PA: Saunders; 2006.
Kern PA.
Adipose tissue gene
expression in the context of inflammation and obesity. In: Meskin MS, editor. Phytochemicals: Nutrient-gene interactions.
Boca Raton: CRC Taylor & Francis; 2006. p. 83-96.
Kohli M, Viswamitraa S, Schaefer R,
Faas FH, Kumar U.
Metastasectomy for isolated bilateral adrenal metastases in
hormone-refractory prostate cancer. Clin Adv Hematol Oncol
2006; 4(10):754-5.
Kousteni S,
Almeida M, Han L, Warren A, Lowe V,
Manolagas SC. Estrogens
control the birth and apoptosis of bone cells in mice in which
ERa
cannot interact with DNA (ERaNERKI/-).
J Bone Miner Res 20[suppl 1], 1098. 2005.
Kousteni S, Almeida M, Han L, Bellido T, Jilka RL,
Manolagas SC. Induction of osteoblast differentiation
by selective activation of kinase-mediated actions of the
estrogen receptor. Mol Cell Biol 2007; 27(4):1516-30.
Kumar J, Kumar
A, Das SK, Shukla G,
Sengupta S. Detection of differential gene copy number using
denaturing high performance liquid chromatography. J Biochem
Biophys Methods; 64(3):226-34, 2005.
Kumar J,
Das SK, Sharma P,
Karthikeyan G, Ramakrishnan L, Sengupta S. Homocysteine levels
are associated with MTHFR A1298C polymorphism in Indian
population. J Hum Genet 2005; 50(12):655-63.
Lam HS, Proctor A,
Nyalala J, Morris MD, Smith
WG. Fourier transform infrared spectroscopy evaluation of low
density lipoproteins oxidation in the presence of quercetin,
catechin and alpha-tocopherol. Lipids 2005 June;
40(6):569-74.
Liu Z;Aronson J;Wahl EC;Liu
L;Perrien DS;Kern PA;Fowlkes
JL;Thrailkill KM;Bunn RC;Cockrell GE;Skinner RA;Lumpkin CK; A
novel rat model for the study of deficits in bone formation in
type-2 diabetes. Acta Orthop 2007 Feb 78 (1): 46 - 55.
Makdissi A.,
Zimmerman RS. Humoral hypercalcemia of malignancy in a patient
with large cell carcinoma of the lung: report of case and review
of literature. Endocr Pract. 2007 Jul-Aug; 13(4):389-95.
Malhotra A,
Elbein SC, Ng MC, Duggirala R,
Arya R, Imperatore G, Adeyemo A, Pollin TI, Hsueh WC, Chan JC,
Rotimi C, Hanson RL, Hasstedt SJ, Wolford JK. Meta-analysis of
genome-wide linkage studies of quantitative lipid traits in
families ascertained for type 2 diabetes. Diabetes 2007;
56(3):890-6.
Manolagas SC.
Pathogenesis of fractures in glucocorticoid-induced
osteoporosis. Straub N, editor. 4-13. 2005. New Jersey,
Excerpta Medica, an Elsevier business. Treatment and prevention
of osteoporosis: An Opportunity Missed?
Manolagas
SC, Jilka RL, Kousteni S,
Bellido T, Weinstein RS, O'Brien CA, Plotkin L, Han L.
Response to Windahl et al. J Clin Invest 2006; 116(11):2834.
Manolagas
SC, Almeida M. Gone with the Wnts: beta-catenin,
T-cell factor, forkhead box O, and oxidative stress in
age-dependent diseases of bone, lipid, and glucose metabolism.
Mol Endocrinol 2007 Nov; 21(11):2605 - 2614.
Manolagas
SC. (In Press). De-fense! De-fense! Defense:
scavenging H202 while making cholesterol. Endocrinology
2008; 149(7):3267-73.
Mehta JL,
Rasouli, N, Sinha AK, Molavi
B. Oxidative stress in diabetes: a
mechanistic overview of its effects on parthenogenesis and
myocardial dysfunction. Int J Biochem Cell Biol 2006;
38(5-6):794-803.
Molavi B,
Rasouli N, Kern PA. The prevention and treatment of
metabolic syndrome and high-risk obesity. Curr Opin Cardiol
2006; 21(5):479-85.
John O
Nyalala., Jiang Wang.,
An Dang., Fred H Faas.,
Grady Smith. Hypertriglyceridemia and hypercholesterolemia:
effects of drug treatment on fatty acid composition of plasma
lipids and membranes.. Prostaglandins, Leuoktrienes and
Essential Fatty Acids 2008 78:271-80.
O'Brien CA,
Jilka RL, Fu Q, Stewart S,
Weinstein RS, Manolagas SC.
IL-6 is not required for parathyroid hormone stimulation of
RANKL expression, osteoclast formation, and bone loss in mice.
Am J Physiol Endocrinol Metab; 289(5):E784-E793, 2005.
1.
O’Brien CA, Plotkin LI, Galli C, Goellner JJ,
Gortazar AR, Allen MR, Robling A, Bouxsein M, Schipani E, Turner
CH, Jilka RL, Weinstein RS, Manolagas
SC, Bellido T. Control of Bone Mass and Remodeling
by PTH Receptor Signaling in Osteocytes.
PLoS ONE, 3(8):
e2942, 2008.
Owen KR, Groves CJ, Hanson RL,
Knowler WC, Shuldiner AR, Elbein SC,
et al. and the International Type 2 Diabetes 1q Consortium.
Common variation in the LMNA gene (encoding Lamin A/C) and type
2 diabetes: association analyses in 9518 subjects. Diabetes
2007;56(3):879-83.
Parfitt AM.
Weight of normal parathyroid glands in patients with parathyroid
adenomas. J Clin Endocrinol Metab 2005; 90(1):595.
Parfitt AM.
Vitamin D and the pathogenesis of rickets and osteomalacia. In:
Feldman D, Glorieux F, Pike W, editors. Vitamin D. 2nd
ed. San Diego, CA: Academic Press, Inc.; 2005. p. 1029-45.
Parfitt AM.
Modeling and remodeling: how bone cells work together. In:
Feldman D, Glorieux F, Pike W, editors. Vitamin D. 2nd
ed. San Diego, CA: Academic Press, Inc.; 2005. p. 497-513.
Parfitt AM.
Vitamin D and the pathogenesis of rickets and osteomalacia. In:
Feldman D, Glorieux F, Pike W, editors. Vitamin D. 2nd
ed. San Diego, CA: Academic Press, Inc.; 2005. p. 1029-45.
Parfitt AM. Misconceptions V –
Activation of osteoclasts is the first step in the bone
remodeling cycle. Bone 2006; 39:1170-1172.
Parfitt AM.
Regulation or
Permission? Journal of Bone Mineral Research 2007;
21(5):659-60.
Parsons CA,
Mroczkowski HJ, McGuigan FE, Albagha OM,
Manolagas S, Reid DM, Ralston SH, Reis RJ.
Interspecies synteny mapping identifies a quantitative trait
locus for bone mineral density on human chromosome Xp22. Hum
Mol Genet; 14(21):3141-8, 2005.
Pineyro MM.,
Makdissi A., Faiman C., Prayson RA., Reddy SK.,
Mayberg MC., Weil RJ., Hamrahian AH. Poor Correlation of Serum
alpha-subunit concentration and magnetic resonance imaging
following pituitary surgery in patients with nonfunctional
pituitary macroadenomas. Endoc Pract. 2008 May-June;
14(4):452-7.
Plotkin LI,
Aguirre JI, Kousteni S,
Manolagas SC, Bellido T. Bisphosphonates and
estrogens inhibit osteocyte apoptosis via distinct molecular
mechanisms downstream of extracellular signal-regulated kinase
activation. J Biol Chem; 280(8):7317-25, 2005.
Plotkin LI,
Mathov I, Aguirre JI, Parfitt AM,
Manolagas SC, Bellido T. Mechanical
stimulation prevents osteocyte apoptosis: requirement of
integrins, Src kinases, and ERKs. Am J Physiol Cell Physiol;
289(3):C633-C643, 2005.
Plotkin LI,
Manolagas SC, Bellido T. Dissociation of the
pro-apoptotic effects of bisphosphonates on osteoclasts from
their anti-apoptotic effects on osteoblasts/osteocytes with
novel analogs. Bone 2006; 39(3):443-52.
Plotkin LI,
Manolagas SC, Bellido T. Glucocorticoids induce
osteocyte apoptosis by blocking focal adhesion kinase-mediated
survival. Evidence for inside-out signaling leading to anoikis.
J Biol Chem 2007 Aug; 282(33):24120 - 24130.
Qiu S, Rao DS,
Fyhrie DP, Palnitkar S, Parfitt AM.
The morphological association between microcracks and osteocyte
lacunae in human cortical bone. Bone; 37(1):10-5, 2005.
Qiu S, Rao DS, Palnitkar S,
Parfitt AM. Independent and
combined contributions of cancellous and cortical bone deficits
to vertebral fracture risk in postmenopausal women. J Bone Miner
Res 2006; 21(11):1791-6.
Ranganathan G,
Pokrovskaya I, Ranganathan S, Kern PA.
Role of a kinase anchor proteins in the tissue-specific
regulation of lipoprotein lipase. Mol Endocrinol;
19(10):2527-34, 2005.
Ranganathan
G, Unal R,
Pokrovskaya I, Yao-Borengasser A,
Phanavanh B, Lecka-Czernik B, Rasouli
N, Kern PA. The lipogenic enzymes DGAT1, FAS, and LPL
in adipose tissue: effects of obesity, insulin resistance, and
TZD treatment. J Lipid Res 2006; 47(11):2444-50.
Rani D,
Simmons DL. Type 1 diabetes
and hypoglycemia: should celiac disease be considered?
EndoTrends; 12(2):17-8, 2005.
Rasouli N,
Hale T, Kahn SE, Spencer HJ, Elbein SC.
Effects of short-term experimental insulin resistance and family
history of diabetes on pancreatic beta-cell function in
nondiabetic individuals. J Clin Endocrinol Metab;
90(10):5825-33, 2005.
Rasouli N,
Raue U, Miles LM, Lu T, Di Gregorio GB,
Elbein SC, Kern PA. Pioglitazone improves
insulin sensitivity through reduction in muscle lipid and
redistribution of lipid into adipose tissue. Am J Physiol
Endocrinol Metab; 288(5):E930-E934, 2005.
Rasouli N,
Yao-Borengasser A, Miles LM,
Elbein SC, Kern PA. Increased
plasma adiponectin in response to pioglitazone does not result
from increased gene expression. Am J Physiol Endocrinol Metab
2006; 290(1):E42-E46.
Rasouli N,
Kern PA, Reece EA, Elbein
SC. Effects of pioglitazone and metformin on
beta-cell function in nondiabetic subjects at high risk for type
2 diabetes. Am J Physiol Endocrinol Metab 2007;
292(1):E359-E365.
Rasouli N, Molavi B,
Elbein SC, Kern
PA. Ectopic fat accumulation and metabolic syndrome.
Diabetes,
Obesity and Metabolism 2007; 9(1):1-10.
Rasouli N;Spencer
HJ;Rashidi AA;Elbein SC;
Impact of family history of diabetes and ethnicity on -cell
function in obese, glucose-tolerant individuals. J Clin
Endocrinol Metab 2007 Dec 92 (12): 4656 - 4663.
Riggs BL,
Parfitt AM. Drugs used to
treat osteoporosis: the critical need for a uniform nomenclature
based on their action on bone remodeling. J Bone Miner Res
2005; 20(2):177-84.
Robling AG,
Bellido T., Turner CH.
Mechanical stimulation in vivo reduces osteocyte expression of
sclerostin. J Musculoskelet Neuronal Interact 2006; 6:354.
Rodriguez MC, Rani D,
Faas FH. Unusual clinical
course of Graves' thyrotoxicosis and concomitant sarcoidosis:
case report and review of literature. Endocr Pract 2007
Mar; 13(2):159 - 163.
Sharma NK., DAS SK., Mondal AK., Hackney OG.,
Chu WS., Kern PA., Rasouli N.,
Spencer HJ., Yao-Borengasser A., Elbein
SC. Endoplasmic reticulum stress markers are
associated with obesity in nondiabetic subjects. J Clin
Endocrinol Metab 2008 Nov; 93(11):4532-41.
Simmons DL.
Diabetes and menopause. West Indian Med J; 54(suppl
1):26, 2005.
Szumska D, Benes H, Kang P,
Weinstein RS, Jilka RL, Manolagas SC,
Shmookler Reis RJ. A novel locus on the X chromosome regulates
post-maturity bone density changes in mice. Bone 2007;
40(3):758-66.
Unal R.,
Weih F., Schorle H., Herrlich P. Towards dissecting
the complexity of the AP-1 (activator protein 1) family. Adv
Exp Med Biol. 2004 553(331-336)
R. Unal.,
B.A. Ahmed., B.C. Jeffus., J.T. Harney., C.S. Lyle., Y.-K. Wu.,
T.C. Chambers., E.A. Reece ., F. Kilic. At diabetes-like
concentration, glucose down-regulates the placental serotonin
transport system in a cell-cycle-dependent manner. J
Neurochem. 2007 May; 101(4):937-948.
Unal R;Pokrovskaya
I;Tripathi P;Monia BP;Kern
PA;Ranganathan G; Translational regulation of
lipoprotein lipase in adipocytes: depletion of cellular protein
kinase Calpha activates binding of the C subunit of protein
kinase A to the 3'-untranslated region of the lipoprotein lipase
mRNA. Biochem J 2008 Jul 15 413 (2): 315 - 322.
Varma V,
Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B,
Lee MJ, Starks T, Kern LM, Spencer HJ, III, McGehee RE, Jr.,
Fried SK, Kern PA. Human
visfatin expression: relationship to insulin sensitivity,
intramyocellular lipid and inflammation. J Clin Endocrinol Metab 2007;
92(2):666-72.
Varma
V;Yao-Borengasser A;Bodles AM;Rasouli N;Phanavanh
B;Nolen GT;Kern EM;Nagarajan R;Spencer HJ;Lee MJ;Fried
SK;McGehee RE;Peterson CA;Kern PA;
Thrombospondin-1 is an adipokine associated with obesity,
adipose inflammation, and insulin resistance. Diabetes 2008 Feb
57 (2): 432 - 439.
Verma R,
Mukerji M, Grover D, Rao C, Das SK,
Kubendran S, Jain S, Brahmachari SK. MLC1 gene is
associated with schizophrenia and bipolar disorder in Southern
India. Biol Psychiatry; 58(1):16-22, 2005.
Verma R,
Kubendran S, Das SK, Jain S,
Brahmachari SK. SYNGR1 is associated with schizophrenia and
bipolar disorder in southern India. J Hum Genet;
50(12):635-40, 2005.
Vertino AM,
Bula CM, Chen JR, Almeida M, Han
L, Bellido T, Kousteni S, Norman AW,
Manolagas SC. Nongenotropic, anti-apoptotic signaling
of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand
binding domain of the vitamin D receptor in osteoblasts and
osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK
kinases. J Biol Chem; 280(14):14130-7, 2005.
Wang
H, Chu W, Wang X, Zhang Z,
Elbein SC. Evaluation of
sequence variants in the pre-B cell leukemia transcription
factor 1 gene: a positional and functional candidate for type 2
diabetes and impaired insulin secretion. Mol Genet Metab;
86(3):384-91, 2005.
Wang H,
Zhang Z, Chu W, Hale T, Cooper JJ,
Elbein SC. Molecular screening and association
analyses of the interleukin 6 receptor gene variants with type 2
diabetes, diabetic nephropathy, and insulin sensitivity. J
Clin Endocrinol Metab; 90(2):1123-9, 2005.
Wang H,
Elbein SC. Detection of allelic imbalance in gene
expression using pyrosequencing(r). Methods Mol Biol 2007;
373:157-76.
Weinstein RS.
Guardian or gate crasher? BoneKey-Osteovision
2005;2:6-13. Available at: URL: http://www.bonekey-ibms.org/cgi/content/full/ibmske;2/9/6?ct.
Weinstein RS,
Manolagas SC.
Apoptosis in glucocorticoid-induced bone disease. Current
Opinion in Endocrinology and Diabetes; 12:219-23, 2005.
Weinstein RS,
Roberson PK,
Manolagas SC.
Giant Osteoclast
Formation and Long-term Oral Bisphosphonate Therapy. NEJM 2009;
360:53-62.
Whelton PK,
Barzilay J, Cushman WC, Davis BR, Iiamathi E, Kostis JB, Leenen
FH, Louis GT, Margolis KL, Mathis DE, Moloo J, Nwachuku C,
Panebianco D, Parish DC, Pressel S,
Simmons DL, Thadani U. Clinical outcomes in
antihypertensive treatment of type 2 diabetes, impaired fasting
glucose concentration, and normoglycemia: Antihypertensive and
Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med; 165(12):1401-9, 2005.
Wright JT;Harris-Haywood S;Pressel
S;Barzilay J;Baimbridge C;Bareis CJ;Basile JN;Black HR;Dart
R;Gupta AK;Hamilton BP;Einhorn PT;Haywood LJ;Jafri SZ;Louis
GT;Whelton PK;Scott CL;Simmons DL;Stanford
C;Davis BR; Clinical outcomes by race in hypertensive patients
with and without the metabolic syndrome: Antihypertensive and
Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med 2008 Jan 28 168 (2): 207 - 217.
Wolins NE, Quaynor BK, Skinner JR,
Tzekov A, Croce MA, Gropler MC, Varma
V, Yao-Borengasser A, Rasouli N, Kern PA, Finck BN,
Bickel PE. OXPAT/PAT-1 is a PPAR-induced lipid droplet protein
that promotes fatty acid utilization. Diabetes 2006;
55(12):3418-28.
Yang P,
Medan MS, Watanabe G, Taya K. Developmental changes of plasma
inhibin, gonadotropins, steroid hormones, and thyroid hormones
in male and female Shao ducks. Gen Comp Endocrinol;
143(2):161-7, 2005.
Yang P,
Medan MS, Arai KY, Jin W, Watanabe G, Taya K. Ontogeny of
testicular inhibin and activin in ducks: An immunocytochemical
analysis. Animal Science Journal; 76(5):427-34, 2005.
Yang P,
Medan MS, Arai KY, Watanabe G, Taya K. Plasma concentrations of
immunoreactive (ir)-inhibin, gonadotropins and steroid hormones
during the ovulatory cycle of the duck. J Reprod Dev;
51(3):353-8, 2005.
Yang P,
Medan MS, Arai KY, Jin W, Watanabe G, Taya K. Secretion of
inhibin and testicular expression of inhibin subunits in male
duck embryos and newly hatched ducks. Endocrine;
28(2):171-80, 2005.
Yao-Borengasser
A, Rasouli N, Varma V, Miles LM, Phanavanh B, Starks
TN, Phan J, Spencer HJ, III, McGehee RE, Jr., Reue K,
Kern PA. Lipin expression is
attenuated in adipose tissue of insulin-resistant human subjects
and increases with peroxisome proliferator-activated receptor
gamma activation. Diabetes 2006; 55(10):2811-8.
Yao-Borengasser
A;Varma V;Bodles AM;Rasouli N;Phanavanh B;Lee
MJ;Starks T;Kern LM;Spencer HJ;Rashidi AA;McGehee RE;Fried SK;Kern
PA; Retinol binding protein 4 expression in humans:
relationship to insulin resistance, inflammation, and response
to pioglitazone. J Clin Endocrinol Metab 2007 Jul 92 (7):
2590 - 2597.
Yao-Borengasser
A., Rassouli N., Varma V., Bodles AM., Rasouli N., Unal R.,
Phanavanh B., Ranganathan G.,
McGehee RE Jr., Kern PA.
Stearoyl-CoA Desaturase 1 (SCD1) Gene Expression increases
following pioglitazone treatment and is associated with PPAR?
responsiveness in Humans.. J Clin Endocrinol Metab. 2008
August;
Zeggini E, Damcott CM, Hanson RL,
Karim MA, Rayner NW, Groves CJ, Baier LJ, Hale TC, Hattersley
AT, Hitman GA, Hunt SE, Knowler WC, Mitchell BD, Ng MC,
O'Connell JR, Pollin TI, Vaxillaire M, Walker M, Wang X,
Whittaker P, Xiang K, Jia W,
Chan JC, Froguel P, Deloukas P,
Shuldiner AR, Elbein SC,
McCarthy MI. Variation within the gene encoding the upstream
stimulatory factor 1 does not influence susceptibility to type 2
diabetes in samples from populations with replicated evidence of
linkage to chromosome 1q. Diabetes 2006; 55(9):2541-8.
Weinstein
RS, Roberson PK, Manolagas
SC. Giant osteoclast formation and long-term oral
bisphosphonate therapy. NEJM
2009 Jan 1;360(1):53-62.
|
